Suppr超能文献

2016年加拿大实验室人员接触人类病原体和毒素情况监测

Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.

作者信息

Bienek A, Heisz M, Su M

机构信息

Centre for Biosecurity, Public Health Agency of Canada, Ottawa, ON.

出版信息

Can Commun Dis Rep. 2017 Nov 2;43(11):228-235. doi: 10.14745/ccdr.v43i11a04.

Abstract

BACKGROUND

Canada recently enacted legislation to authorize the collection of data on laboratory incidents involving a biological agent. This is done by the Public Health Agency of Canada (PHAC) as part of a comprehensive national program that protects Canadians from the health and safety risks posed by human and terrestrial animal pathogens and toxins.

OBJECTIVE

To describe the first year of data on laboratory exposure incidents and/or laboratory-acquired infections in Canada since the came into effect.

METHODS

Incidents that occurred between January 1 and December 31, 2016 were self-reported by federally-regulated parties across Canada using a standardized form from the Laboratory Incident Notification Canada (LINC) surveillance system. Exposure incidents were described by sector, frequency of occurrence, timeliness of reporting, number of affected persons, human pathogens and toxins involved, causes and corrective actions taken. Microsoft Excel 2010 was used for basic descriptive analyses.

RESULTS

In 2016, 46 exposure incidents were reported by holders of 835 active licences in Canada representing 1,352 physical areas approved for work involving a biological agent, for an overall incidence of 3.4%. The number of incidents was highest in the academic (n=16; 34.8%) and hospital (n=12; 26.1%) sectors, while the number of reported incidents was relatively low in the private industry sector. An average of four to five incidents occurred each month; the month of September presented as an outlier with 10 incidents. A total of 100 people were exposed, with no reports of secondary exposure. Four incidents led to suspected (n=3) or confirmed (n=1) cases of laboratory-acquired infection. Most incidents involved pathogens classified at a risk group 2 level that were manipulated in a containment level 2 laboratory (91.3%). Over 22 different species of human pathogens and toxins were implicated, with bacteria the most frequent (34.8%), followed by viruses (26.1%). Eleven (23.9%) incidents involved a security sensitive biologic agent. Procedure breaches (n=15) and sharps-related incidents (n=14) were the most common antecedents to an exposure. In 10 (21.7%) cases, inadvertent possession (i.e., isolation of an unexpected biological agent during routine work) played a role. Possible improvements to standard operating procedures were cited in 71.7% of incidents. Improvements were also indicated for communication (26.1%) and management (23.9%).

CONCLUSIONS

The Laboratory Incident Notification Canada is one of the first surveillance systems in the world to gather comprehensive data on laboratory incidents involving human pathogens and toxins. Exposure incidents reported in the first year were relatively rare, occurring in less than 4% of containment zones within laboratory settings.

摘要

背景

加拿大最近颁布了立法,授权收集涉及生物制剂的实验室事故数据。这由加拿大公共卫生署(PHAC)负责,是一项全面国家计划的一部分,该计划旨在保护加拿大人免受人类和陆生动物病原体及毒素带来的健康和安全风险。

目的

描述自[相关法规]生效以来加拿大实验室暴露事故和/或实验室获得性感染数据的第一年情况。

方法

2016年1月1日至12月31日期间发生的事故由加拿大全国受联邦监管的各方使用加拿大实验室事故通报(LINC)监测系统的标准化表格进行自我报告。暴露事故按部门、发生频率、报告及时性、受影响人数、涉及的人类病原体和毒素、原因以及采取的纠正措施进行描述。使用Microsoft Excel 2010进行基本描述性分析。

结果

2016年,加拿大持有835个有效许可证的机构报告了46起暴露事故,这些许可证涵盖1352个经批准可进行涉及生物制剂工作的物理区域,总体发生率为3.4%。事故数量在学术部门(n = 16;34.8%)和医院部门(n = 12;26.1%)最高,而私营行业部门报告的事故数量相对较低。平均每月发生四至五起事故;9月出现异常,有10起事故。共有100人暴露,无二次暴露报告。四起事故导致疑似(n = 3)或确诊(n = 1)的实验室获得性感染病例。大多数事故涉及在2级防护实验室中操作的风险等级为2级的病原体(91.3%)。涉及超过22种不同的人类病原体和毒素,其中细菌最为常见(34.8%),其次是病毒(26.1%)。11起(23.9%)事故涉及安全敏感生物制剂。程序违规(n = 15)和锐器相关事故(n = 14)是暴露最常见的前因。在10起(21.7%)案例中,无意中持有(即在常规工作中分离出意外的生物制剂)起到了作用。71.7%的事故提到了对标准操作程序可能的改进。在沟通(26.1%)和管理(23.9%)方面也指出了改进之处。

结论

加拿大实验室事故通报是世界上首批收集涉及人类病原体和毒素的实验室事故综合数据的监测系统之一。第一年报告的暴露事故相对较少,发生在实验室环境中不到4%的防护区域内。

相似文献

8
Laboratory-acquired infections in Canada from 2016 to 2021.2016年至2021年加拿大的实验室获得性感染
Can Commun Dis Rep. 2022 Jul 7;48(7-8):303-307. doi: 10.14745/ccdr.v48i78a02.

引用本文的文献

5
Laboratory-acquired infections in Canada from 2016 to 2021.2016年至2021年加拿大的实验室获得性感染
Can Commun Dis Rep. 2022 Jul 7;48(7-8):303-307. doi: 10.14745/ccdr.v48i78a02.

本文引用的文献

1
Regulatory oversight of human pathogens and toxins in Canada.加拿大对人类病原体和毒素的监管。
Can Commun Dis Rep. 2015 Dec 17;41(Suppl 6):14-18. doi: 10.14745/ccdr.v41is6a03.
6
Brucellae growing on Thayer-Martin medium: a source of inadvertent exposure for laboratory personnel in endemic areas.
J Med Microbiol. 2014 Jan;63(Pt 1):148-149. doi: 10.1099/jmm.0.064121-0. Epub 2013 Sep 26.
7
A literature review of laboratory-acquired brucellosis.实验室获得性布鲁氏菌病的文献综述。
J Clin Microbiol. 2013 Sep;51(9):3055-62. doi: 10.1128/JCM.00135-13. Epub 2013 Jul 3.
9
Laboratory-acquired infections.实验室获得性感染。
Clin Infect Dis. 2009 Jul 1;49(1):142-7. doi: 10.1086/599104.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验